Aboulafia David M, Pantanowitz Liron, Dezube Bruce J
Division of Hematology, University of Washington, Seattle, USA.
AIDS Read. 2004 Nov;14(11):605-17.
Despite advances in HAART, patients with HIV infection remain at significantly increased risk for intermediate- and high-grade B-cell non-Hodgkin lymphoma. The reasons for this persistent risk and the clinical and molecular correlates that predict outcomes and treatment responsiveness are areas of active investigation. Here we review the epidemiologic and pathobiologic features of AIDS-related lymphoma along with clinical evaluation and treatment options in patients with this disease.
尽管高效抗逆转录病毒治疗(HAART)取得了进展,但HIV感染患者发生中高级别B细胞非霍奇金淋巴瘤的风险仍显著增加。这种持续存在的风险原因以及预测预后和治疗反应性的临床和分子相关性是当前积极研究的领域。在此,我们综述了艾滋病相关淋巴瘤的流行病学和病理生物学特征,以及该疾病患者的临床评估和治疗选择。